Abstract Title:

Rhabdomyolysis with atorvastatin and fusidic acid.

Abstract Source:

Postgrad Med J. 2008 Jun ;84(992):325-7. PMID: 18644925

Abstract Author(s):

C O'Mahony, V L Campbell, M S Al-Khayatt, D J Brull

Article Affiliation:

The Heart Hospital, 16-18 Westmoreland Street, London W1G 8PH, UK. [email protected]

Abstract:

Rhabdomyolysis is a rare but life-threatening complication of statin therapy. A 74-year-old man, treated with atorvastatin, developed rhabdomyolysis after the co-administration of fusidic acid and flucloxacillin. The patient recovered with supportive treatment and subsequently tolerated reintroduction of atorvastatin. Pharmacokinetic interactions can cause raised plasma statin concentrations, which can precipitate rhabdomyolysis in the presence of certain predisposing biological factors.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.